Intellia Therapeutics (NTLA) Cash & Equivalents (2015 - 2026)
Intellia Therapeutics' Cash & Equivalents was $106.13 million in Q2 2026, down 32.0% from $156.17 million a year earlier and down 21.2% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Cash & Equivalents (2015 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Intellia Therapeutics came in at $155.46 million, down 17.8% from FY2024.
- Cash & Equivalents has now declined for three consecutive years, with a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $189.18 million in FY2024 (-16.6%), $226.75 million in FY2023 (-56.7%), $523.51 million in FY2022 (+317.2%) and $125.49 million in FY2021 (-21.6%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q1 2020.
- Compared with a year earlier, Cash & Equivalents was higher in three of the last eight quarters, with an average decline of 4.4%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2022 (growth of 317.2%); the worst was Q3 2022 (a decline of 57.8%).
- Per Business Quant data, NTLA's Cash & Equivalents in the three quarters before Q2 2026 was $134.7 million (Q1 2026), $155.46 million (Q4 2025) and $193.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Intellia Therapeutics | 1.70 Bn | 1.70 Bn | - | 106.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.13 Mn |
| Mar 31, 2026 | 134.70 Mn |
| Dec 31, 2025 | 155.46 Mn |
| Sep 30, 2025 | 193.39 Mn |
| Jun 30, 2025 | 156.17 Mn |
| Mar 31, 2025 | 126.88 Mn |
| Dec 31, 2024 | 189.18 Mn |
| Sep 30, 2024 | 120.50 Mn |
| Jun 30, 2024 | 130.85 Mn |
| Mar 31, 2024 | 171.98 Mn |
| Dec 31, 2023 | 226.75 Mn |
| Sep 30, 2023 | 168.03 Mn |
| Jun 30, 2023 | 171.81 Mn |
| Mar 31, 2023 | 294.15 Mn |
| Dec 31, 2022 | 523.51 Mn |
| Sep 30, 2022 | 141.19 Mn |
| Jun 30, 2022 | 147.78 Mn |
| Mar 31, 2022 | 133.38 Mn |
| Dec 31, 2021 | 125.49 Mn |
| Sep 30, 2021 | 334.74 Mn |
API Access
Intellia Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();